- MACK Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Merrimack Pharmaceuticals (MACK) 10-K/A2016 FY Annual report (amended)
Filed: 1 May 17, 12:00am
Exhibit 31.4
CERTIFICATIONS
I, Yasir B. Al-Wakeel, BM BCh, certify that:
1. I have reviewed this Amendment No. 1 to the Annual Report on Form10-K of Merrimack Pharmaceuticals, Inc.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
Date: May 1, 2017 | /s/ Yasir B. Al-Wakeel, BM BCh | |
Yasir B. Al-Wakeel, BM BCh | ||
Chief Financial Officer and Head of Corporate Development | ||
(Principal Financial Officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.